| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |